Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Effect of CD56 Expression on Prognosis of AML Patients with AML/ETO Mutation].

Zhongguo shi yan xue ye xue za zhi - 1 Feb 2020

Zhao Juan, Zhang Hai-Tao

Abstract excerpt

OBJECTIVE: To investigate the expression and prognostic significance of CD56 in the patients suffered from acute myeloid leukemia with AML/ETO mutation. METHODS: The clinical data of 60 newly diagnosed AML patients with AML/ETO from January 2012 to December 2016 were analyzed retrospectively. The clinical characteristics and outcome between CD56+ and CD56- patients were compared. RESULTS: There were significant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD56 Antigen
Share to Leukemia, Myeloid, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to RUNX1 Translocation Partner 1 Protein

Source

Identifiers

PMID: 32027254
DOI: 10.19746/j.cnki.issn.1009-2137.2020.01.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Effect of CD56 Expression on Prognosis of AML Patients with AML/ETO Mutation].PMID 32027254Read ↗

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia.Semantic proximity Read ↗

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemiaSemantic proximity Read ↗

The role of CD56 in predicting the prognosis of AML in childrenSemantic proximity Read ↗

A Case of AML1/ETO Positive Child with Acute Myeloid Leukemia with Poor Prognosis.Semantic proximity Read ↗

[Clinical features and prognostic factors in adult acute myeloid leukemia patients with FLT3-ITD and CEBPA gene co-mutation].Semantic proximity Read ↗

[Relation of ASXL2 Gene Mutation with Clinical Characteristics, Prognosis and C-KIT Gene Mutation in AML Patients with AML1- ETO Fusion Gene].Semantic proximity Read ↗

[EVI1 expression, clinical and cytogenetical characteristics in 447 patients with acute myeloid leukemia].Semantic proximity Read ↗

[Advances of Targeting Therapy in Acute Myeloid Leukemia--Review].Semantic proximity Read ↗

[The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia].Semantic proximity Read ↗

[Expression of CD19 and CD56 in AML Patients with RUNX1-RUNX1T1 Mutation and Its Clinical Significance].Semantic proximity Read ↗

[Outcome of acute myeloid leukemia with FLT3-ITD mutation treated by allogeneic hematopoietic stem cell transplantation].Semantic proximity Read ↗

[Clinical Characteristics and Prognosis of U2AF1 Mutation in Patients with Acute Myeloid Leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.